文献速递免疫规划传染病防控与疫情报告

马匹接种商业多价非洲马瘟减毒活疫苗后非洲马瘟病毒核酸与抗体的动态变化

Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine.
PubMed 文献 · Vaccine · 2017-03-22

本研究对比马匹接种商业多价非洲马瘟减毒活疫苗后,利用群特异性及型特异性RT-qPCR检测病毒RNA血症与血清中和试验检测抗体反应的动态和持续时间。结果显示接种马匹出现延长的RNA血症,且先接种含1、3、4型疫苗再接种含2、6、7、8型疫苗时,更多马匹在群特异性RT-qPCR中呈阳性且Cq值更低;间隔4周接种比间隔更长或12周接种Cq值更低。

要点

  • 接种非洲马瘟减毒活疫苗后马匹可出现延长的RNA血症。
  • 先接种含1、3、4型疫苗再接种含2、6、7、8型疫苗时,群特异性RT-qPCR阳性马匹更多且Cq值更低。
  • 间隔4周接种疫苗比间隔更长或12周接种获得的Cq值更低。

核心结论

  • 接种非洲马瘟减毒活疫苗的马匹出现延长的RNA血症,疫苗病毒核酸可能干扰诊断检测结果的准确解读。

研究设计与样本

  • 研究对比马匹接种商业多价非洲马瘟减毒活疫苗后RNA血症动态与血清学反应,使用群特异性和型特异性RT-qPCR及血清中和试验。

主要发现

  • 接种马匹出现延长的RNA血症。
  • 先接种含1、3、4型疫苗再接种含2、6、7、8型疫苗时,更多马匹在群特异性RT-qPCR中呈阳性且Cq值更低,而非疫苗组合顺序相反时。
  • 间隔4周接种疫苗比间隔更长或12周接种获得的Cq值更低。

临床怎么用

  • 在应用非洲马瘟减毒活疫苗的地区,疫苗使用可能使诊断检测结果的准确解读变得复杂。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

African horse sickness (AHS) is a fatal disease of equids relevant to the global equine industry. Detection of AHS virus (AHSV) during outbreaks has become more rapid and efficient with the advent of group specific reverse transcriptase quantitative polymerase chain reaction (GS RT-qPCR) assays to detect AHSV nucleic acid. Use of GS RT-qPCR together with recently described type specific (TS RT-qPCR) assays cannot only expedite diagnosis of AHS but also facilitate further evaluation of the dynamics of AHSV infection in the equine host. A potential limitation to the application of these assays is that they detect viral nucleic acid originating from any AHS live attenuated vaccine (LAV), which is the vaccine type routinely administered to horses in South Africa. The aim of this study was to contrast the dynamics and duration of the RNAaemia to the serological responses of horses following immunization with a commercial polyvalent AHSV-LAV using GS and TS RT-qPCR assays and serum neutralisation tests. The results of the study showed extended RNAemia in vaccinated horses, and that more horses tested positive on GS RT-qPCR with lower Cq values after receiving the AHSV-LAV containing types 1, 3 and 4 prior to the vaccine containing types 2, 6, 7 and 8, rather than when the vaccine combinations were reversed. Furthermore, lower Cq values were obtained when vaccines were administered 4weeks apart as compared with a longer interval or 12weeks apart. These findings are of particular relevance in regions where AHSV-LAVs are used as the use of these vaccines may complicate the accurate interpretation of diagnostic testing results.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Weyer CT, Grewar JD, Burger P, et al. Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine. Vaccine. 2017. PMID: 28341113. doi:10.1016/j.vaccine.2017.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。